Company intelligence / Profile preview

Amarantus BioScience

San Francisco Bay Area, California, United States
Ownership
Private
Development stage
Other
01

Overview

Amarantus developed biologics (notably MANF protein therapeutics) for neurodegenerative and regenerative indications, had positive early- and mid-stage clinical and preclinical results for Parkinson's, traumatic brain injury; licensed programs to Emerald in 2019 including near Phase 3-ready candidates; diagnostics for Alzheimer’s and MS were licensed/joint-ventured.[2][4][5]

Therapeutic areas
OphthalmologyPsychiatryDermatologyCardiovascularNeurology
Modalities
ProteinRecombinant proteinSmall moleculeEngineered skin substitute (biologic/device)
Industry
Biotech
02

Drug pipeline

2 assets

AMRS-001

Preclinical

1 more asset in the full pipeline.

Request access →
03

Partnerships

Emerald Organic Growth (now Emerald Life Sciences): licensed all therapeutic assetsTodos Medical: joint venture for diagnostics (Alzheimer’s, MS)Coeptis Pharmaceutical: acquisition of Elto Pharma (eltoprazine)

Beyond the preview

Go deeper on Amarantus BioScience.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Amarantus BioScience.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call